The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Open accessAbstract
Peptide therapeutics have played a notable role in medical practice since the advent of insulin therapy in the 1920s. Over 60 peptide drugs are approved in the United States and other major markets, and peptides continue to enter clinical development at a steady pace. Peptide drug discovery has diversified beyond its traditional focus on endogenous human peptides to include a broader range of structures identified from other natural sources or through medicinal chemistry efforts. We maintain a comprehensive dataset on peptides that have entered human clinical studies that includes over 150 peptides in active development today. Here we provide an overview of the peptide therapeutic landscape, including historical perspectives, molecular characteristics, regulatory benchmarks, and a therapeutic area breakdown.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Peptides (2–50 amino acids) and proteins (more than 50 amino acids) have better selectivity for human specific targets. The larger molecular size and diverse quaternary structure enhance their interaction with specific protein pockets, making peptides and protein drugs have better biological activity and lower toxicity than small molecules.294,295”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [294]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Müller, A., Schäberle, T. F., Hughes, D. E., Epstein, S. S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.esgl · Cited by 1,140
Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70379-1 · Cited by 1,052
Advances in Fmoc solid‐phase peptide synthesis
Behrendt, R., White, P., & Offer, J. (2016) · Journal of Peptide Science · doi:10.1002/psc.2836 · Cited by 767
(1922) · PubMed · Cited by 753
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
Finan, B., Ma, T., Ottaway, N., Müller, T. D., Habegger, K. M., Heppner, K. M., Kirchner, H., Holland, J., Hembree, J., Raver, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007218 · Cited by 696
Chang, Y. S., Graves, B. J., Guerlavais, V., Tovar, C., Packman, K. E., To, K.-H., Olson, K. A., Kesavan, K. P., Gangurde, P., Mukherjee, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303002110 · Cited by 681
Strategic Approaches to Optimizing Peptide ADME Properties
Di, L. (2015) · The AAPS Journal · doi:10.1208/s12248-014-9687-3 · Cited by 669
Large-scale manufacture of peptide therapeutics by chemical synthesis
Bray, B. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1133 · Cited by 601
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
Romere, C., Duerrschmid, C., Bournat, J., Constable, P., Jain, M., Xia, F., Saha, P. K., Del Solar, M., Zhu, B., York, B., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.063 · Cited by 591
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Therapeutic Peptides: Current Applications and Future Directions
Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00904-4 · Cited by 2,131
Trends in peptide drug discovery
Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00135-8 · Cited by 2,074
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes
Kumari, S., Carmona, A. V., Tiwari, A. K., & Trippier, P. C. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00530 · Cited by 692
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
Chen, C. H., & Lu, T. K. (2020) · Antibiotics · doi:10.3390/antibiotics9010024 · Cited by 600
Understanding Cell Penetration of Cyclic Peptides
Dougherty, P. G., Sahni, A., & Pei, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00008 · Cited by 598
Multifunctional biomolecule nanostructures for cancer therapy
Wang, J., Li, Y., & Nie, G. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00315-x · Cited by 513
Antimicrobial peptides as therapeutic agents: opportunities and challenges
Mahlapuu, M., Björn, C., & Ekblom, J. (2020) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2020.1796576 · Cited by 501
Sustainability Challenges in Peptide Synthesis and Purification: From R&D to Production
Isidro‐Llobet, A., Kenworthy, M. N., Mukherjee, S., Kopach, M. E., Wegner, K., Gallou, F., Smith, A. G., & Roschangar, F. (2019) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.8b03001 · Cited by 493
Chemically modified and conjugated antimicrobial peptides against superbugs
Li, W., Separovic, F., O’brien-simpson, N. M., & Wade, J. D. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01026j · Cited by 443
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Zheng, W., Hu, Y., & Shi, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02107-5 · Cited by 449
Thapa, R. K., Diep, D. B., & Tønnesen, H. H. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.12.025 · Cited by 380
Antimicrobial peptides under clinical investigation
Koo, H. B., & Seo, J. (2019) · Peptide Science · doi:10.1002/pep2.24122 · Cited by 377
Mechanochemistry: New Tools to Navigate the Uncharted Territory of “Impossible” Reactions
Cuccu, F., Luca, L. D., Delogu, F., Colacino, E., Solin, N., Mocci, R., & Porcheddu, A. (2022) · ChemSusChem · doi:10.1002/cssc.202200362 · Cited by 354
ToxinPred 3.0: An improved method for predicting the toxicity of peptides
Rathore, A. S., Choudhury, S., Arora, A., Tijare, P. A., & Raghava, G. P. S. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108926 · Cited by 365
Peptide-based drug discovery: Current status and recent advances
Sharma, K., Sharma, K. K., Sharma, A., & Jain, R. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103464 · Cited by 321
New keys for old locks: carborane-containing drugs as platforms for mechanism-based therapies
Stockmann, P., Gozzi, M., Kuhnert, R., Sárosi, M. B., & Hey‐Hawkins, E. (2019) · Chemical Society Reviews · doi:10.1039/c9cs00197b · Cited by 317
Machine intelligence in peptide therapeutics: A next‐generation tool for rapid disease screening
Basith, S., Manavalan, B., Shin, T. H., & Lee, G. (2020) · Medicinal Research Reviews · doi:10.1002/med.21658 · Cited by 316
Barrett, G. C., & Elmore, D. T. (1990) · Royal Society of Chemistry eBooks · doi:10.1039/9781847557483 · Cited by 302
Active targeting of gold nanoparticles as cancer therapeutics
Goddard, Z. R., Marín, M. J., Russell, D. A., & Searcey, M. (2020) · Chemical Society Reviews · doi:10.1039/d0cs01121e · Cited by 292
Advances in therapeutic peptides targeting G protein-coupled receptors
Davenport, A. P., Scully, C. C. G., de Graaf, C., Brown, A., & Maguire, J. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0062-z · Cited by 279
Santos, K. B., Guedes, I. A., Karl, A. L. M., & Dardenne, L. E. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00905 · Cited by 273
Large-Scale Analyses of Human Microbiomes Reveal Thousands of Small, Novel Genes
Sberro, H., Fremin, B. J., Zlitni, S., Edfors, F., Greenfield, N., Snyder, M. P., Pavlopoulos, G. A., Kyrpides, N. C., & Bhatt, A. S. (2019) · Cell · doi:10.1016/j.cell.2019.07.016 · Cited by 237
High‐Aspect‐Ratio Nanostructured Surfaces as Biological Metamaterials
Higgins, S. G., Becce, M., Belessiotis‐Richards, A., Seong, H., Sero, J., & Stevens, M. M. (2020) · Advanced Materials · doi:10.1002/adma.201903862 · Cited by 254
Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches
Brayden, D. J., Hill, T. A., Fairlie, D. P., Maher, S., & Mrsny, R. J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.007 · Cited by 267
Diehl, C. J., & Ciulli, A. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00387b · Cited by 262
Strategies for Improving Peptide Stability and Delivery
Musaimi, O. A., Lombardi, L., Williams, D. R., & Alberício, F. (2022) · Pharmaceuticals · doi:10.3390/ph15101283 · Cited by 270
Ferrazzano, L., Catani, M., Cavazzini, A., Martelli, G., Corbisiero, D., Cantelmi, P., Fantoni, T., Mattellone, A., Luca, C. D., Felletti, S., et al. (2022) · Green Chemistry · doi:10.1039/d1gc04387k · Cited by 253
Mini Review on Antimicrobial Peptides, Sources, Mechanism and Recent Applications
Boparai, J. K., & Sharma, P. K. (2019) · Protein and Peptide Letters · doi:10.2174/0929866526666190822165812 · Cited by 343
Subcutaneous delivery of monoclonal antibodies: How do we get there?
Viola, M., Sequeira, J. A. D., Seiça, R. M. F., Veiga, F., Serra, J. P., Paiva‐Santos, A. C., & Ribeiro, A. J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.001 · Cited by 247
Goodsell, D. S., Sanner, M. F., Olson, A. J., & Forli, S. (2020) · Protein Science · doi:10.1002/pro.3934 · Cited by 244
Poly(lactic acid)/poly(lactic-co-glycolic acid)-based microparticles: an overview
Blasi, P. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00453-z · Cited by 240
Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era
Rossino, G., Marchese, E., Galli, G., Verde, F., Finizio, M., Serra, M., Linciano, P., & Collina, S. (2023) · Molecules · doi:10.3390/molecules28207165 · Cited by 257
Peptide–nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms?
Jeong, W.-J., Bu, J., Kubiatowicz, L. J., Chen, S. S., Kim, Y. S., & Hong, S. (2018) · Nano Convergence · doi:10.1186/s40580-018-0170-1 · Cited by 230
New insights into protein–protein interaction modulators in drug discovery and therapeutic advance
Nada, H., Choi, Y., Kim, S.-D., Jeong, K. S., Meanwell, N. A., & Lee, K. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02036-3 · Cited by 241
ACPred: A Computational Tool for the Prediction and Analysis of Anticancer Peptides
Schaduangrat, N., Nantasenamat, C., Prachayasittikul, V., & Shoombuatong, W. (2019) · Molecules · doi:10.3390/molecules24101973 · Cited by 220
Hasan, M. M., Schaduangrat, N., Basith, S., Lee, G., Shoombuatong, W., & Manavalan, B. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa160 · Cited by 216
Zhou, X., Smith, Q. R., & Liu, X. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1695 · Cited by 229
Machine learning models for drug–target interactions: current knowledge and future directions
D’Souza, S., Prema, K. V., & Balaji, S. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.03.003 · Cited by 213
AutoDock CrankPep : combining folding and docking to predict protein–peptide complexes
Zhang, Y., & Sanner, M. F. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz459 · Cited by 212
Impact of non-proteinogenic amino acids in the discovery and development of peptide therapeutics
Ding, Y., Ting, J. P., Liu, J., Al-Azzam, S., Pandya, P., & Afshar, S. (2020) · Amino Acids · doi:10.1007/s00726-020-02890-9 · Cited by 200
Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
An, D., Peigneur, S., Hendrickx, L. A., & Tytgat, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145064 · Cited by 201
Buckton, L. K., Rahimi, M. N., & McAlpine, S. R. (2020) · Chemistry - A European Journal · doi:10.1002/chem.201905385 · Cited by 195
Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems
Shi, M., & McHugh, K. J. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114904 · Cited by 194
Peptide and peptide-based inhibitors of SARS-CoV-2 entry
Schütz, D., Ruiz‐Blanco, Y. B., Münch, J., Kirchhoff, F., Sánchez‐García, E., & Müller, J. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.11.007 · Cited by 180
Choosing the Right Coupling Reagent for Peptides: A Twenty-Five-Year Journey
Alberício, F., & El‐Faham, A. (2018) · Organic Process Research & Development · doi:10.1021/acs.oprd.8b00159 · Cited by 183
Advances in the stability challenges of bioactive peptides and improvement strategies
Pei, J., Gao, X., Pan, D., Hua, Y., He, J., Liu, Z., & Dang, Y. (2022) · Current Research in Food Science · doi:10.1016/j.crfs.2022.10.031 · Cited by 194
Peptides as Therapeutic Agents for Inflammatory-Related Diseases
Manna, S. L., Natale, C. D., Florio, D., & Marasco, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092714 · Cited by 183
Propedia: a database for protein–peptide identification based on a hybrid clustering algorithm
Martins, P., Santos, L. H., Mariano, D., Queiroz, F. C., Bastos, L. L., Gomes, I. D. S., Fischer, P., Rocha, R. E. O., Silveira, S. D. A., de Lima, L. H. F., et al. (2021) · BMC Bioinformatics · doi:10.1186/s12859-020-03881-z · Cited by 183
Stapled Peptides Inhibitors: A New Window for Target Drug Discovery
Ali, A. M., Atmaj, J., Oosterwijk, N. V., Groves, M. R., & Dömling, A. S. S. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.01.012 · Cited by 180
de Gonzalo, G., Alcántara, A. R., & de Marı́a, P. D. (2019) · ChemSusChem · doi:10.1002/cssc.201900079 · Cited by 182
Goles, M., Sanchez–Daza, A., Cabas-Mora, G., Varón, L. S., Sepúlveda-Yáñez, J., Anvari-Kazemabad, H., Davari, M. D., Uribe-Paredes, R., Olivera‐Nappa, Á., Navarrete, M. A., et al. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae275 · Cited by 188
Chemical modifications to increase the therapeutic potential of antimicrobial peptides
Han, Y., Zhang, M., Lai, R., & Zhang, Z. (2021) · Peptides · doi:10.1016/j.peptides.2021.170666 · Cited by 171
Orally Active Peptides: Is There a Magic Bullet?
Räder, A. F. B., Weinmüller, M., Reichart, F., Schumacher‐Klinger, A., Merzbach, S., Gilon, C., Hoffman, A., & Kessler, H. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201807298 · Cited by 163
Liquid-Phase Peptide Synthesis (LPPS): A Third Wave for the Preparation of Peptides
Sharma, A., Kumar, A., de la Torre, B. G., & Alberício, F. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00132 · Cited by 163
Intramolecular hydrogen bonding: An opportunity for improved design in medicinal chemistry
Caron, G., Kihlberg, J. O., & Ermondi, G. (2019) · Medicinal Research Reviews · doi:10.1002/med.21562 · Cited by 161
Greening Fmoc/ t Bu solid-phase peptide synthesis
Musaimi, O. A., de la Torre, B. G., & Alberício, F. (2020) · Green Chemistry · doi:10.1039/c9gc03982a · Cited by 166
Antiviral Peptides: Identification and Validation
Agarwal, G., & Gabrani, R. (2020) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-020-10072-0 · Cited by 153
Tian, R., Ma, H., Yang, Q., Wan, H., Zhu, S., Chandra, S., Sun, H., Kiesewetter, D. O., Niu, G., Liang, Y., et al. (2018) · Chemical Science · doi:10.1039/c8sc03751e · Cited by 151
Machine learning-guided discovery and design of non-hemolytic peptides
Plisson, F., Ramírez‐Sánchez, O., & Martínez-Hernández, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-73644-6 · Cited by 153
Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions
Wang, X., Ni, D., Liu, Y., & Lu, S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.682675 · Cited by 159
Anti-cancer peptide-based therapeutic strategies in solid tumors
Fath, M. K., Babakhaniyan, K., Zokaei, M., Yaghoubian, A., Akbari, S., Khorsandi, M., Soofi, A., Nabi‐Afjadi, M., Zalpoor, H., Jalalifar, F., et al. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00332-w · Cited by 152
A comprehensive review of bioactive peptides obtained from animal byproducts and their applications
Bechaux, J., Gatellier, P., Page, J. L., Drillet, Y., & Santé-Lhoutellier, V. (2019) · Food & Function · doi:10.1039/c9fo01546a · Cited by 153
Dairy bioactive proteins and peptides: a narrative review
Auestad, N., & Layman, D. K. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab097 · Cited by 153
Timmons, P. B., & Hewage, C. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-67701-3 · Cited by 153
Peptide based therapeutics and their use for the treatment of neurodegenerative and other diseases
Baig, M. H., Ahmad, K., Saeed, M., Alharbi, A. M., Barreto, G. E., Ashraf, G. M., & Choi, I. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.025 · Cited by 154
Assemblies of Peptides in a Complex Environment and their Applications
Wang, H., Feng, Z., & Xu, B. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201814552 · Cited by 147
Greening the synthesis of peptide therapeutics: an industrial perspective
Martin, V., Egelund, P. H. G., Johansson, H., Quement, S. T. L., Wojcik, F., & Pedersen, D. S. (2020) · RSC Advances · doi:10.1039/d0ra07204d · Cited by 152
Overcoming the Shortcomings of Peptide-Based Therapeutics
Lamers, C. (2022) · Future Drug Discovery · doi:10.4155/fdd-2022-0005 · Cited by 154
Bioactive Peptides as Potential Nutraceuticals for Diabetes Therapy: A Comprehensive Review
Antony, P., & Vijayan, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169059 · Cited by 148
Smart Targeting To Improve Cancer Therapeutics
Morales‐Cruz, M., Delgado, Y., Castillo, B., Figueroa, C. M., Molina, A., Torres, A., Milián, M., & Griebenow, K. H. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s219489 · Cited by 146
Peptide-based protease inhibitors from plants
Hellinger, R., & Gruber, C. W. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.05.026 · Cited by 140
Challenges in delivering therapeutic peptides and proteins: A silk-based solution
Wu, J., Sahoo, J. K., Li, Y., Xu, Q., & Kaplan, D. L. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.011 · Cited by 148
Pickett, J. R., Wu, Y., Zacchi, L. F., & Ta, H. T. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad130 · Cited by 138
Schaduangrat, N., Nantasenamat, C., Prachayasittikul, V., & Shoombuatong, W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225743 · Cited by 143
Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy
Mercer, D. K., Torres, M. D. T., Duay, S. S., Lovie, E., Simpson, L. W., von Köckritz‐Blickwede, M., de la Fuente‐Núñez, C., O′Neil, D. A., & Angeles-Boza, A. M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00326 · Cited by 142
Recent advances in microneedles-mediated transdermal delivery of protein and peptide drugs
Liu, T., Chen, M., Fu, J., Sun, Y. H., Lu, C. T., Quan, G., Pan, X., & Wu, C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.003 · Cited by 133
Costa, F. M. T. A., Teixeira, C. A. S., Gomes, P. A. C., & Martins, M. C. L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3588-4_15 · Cited by 129
Cui, L., Li, H., Xi, Y., Hu, Q., Liu, H., Fan, J., Xiang, Y., Zhang, X., Shui, W., & Lai, Y. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00090-3 · Cited by 142
Simulation-Guided Rational de Novo Design of a Small Pore-Forming Antimicrobial Peptide
Chen, C. H., Starr, C. G., Troendle, E. P., Wiedman, G. R., Wimley, W. C., Ulmschneider, J. P., & Ulmschneider, M. B. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b11939 · Cited by 128
de la Torre, B. G., & Alberício, F. (2020) · Molecules · doi:10.3390/molecules25102293 · Cited by 128
Aroda, V. R., Blonde, L., & Pratley, R. E. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09735-8 · Cited by 135
Short to ultrashort peptide-based hydrogels as a platform for biomedical applications
Yadav, N., Chauhan, M. K., & Chauhan, V. S. (2019) · Biomaterials Science · doi:10.1039/c9bm01304k · Cited by 127
Drug Delivery with Designed Peptide Assemblies
Sis, M. J., & Webber, M. J. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.08.003 · Cited by 125
D’Aloisio, V., Dognini, P., Hutcheon, G. A., & Coxon, C. R. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.02.019 · Cited by 125
Besharati, M., & Lackner, M. K. (2023) · The EuroBiotech Journal · doi:10.2478/ebtj-2023-0013 · Cited by 125
Review of Integrin‐Targeting Biomaterials in Tissue Engineering
Dhavalikar, P., Robinson, A., Lan, Z., Jenkins, D. M. R., Chwatko, M., Salhadar, K., Jose, A., Kar, R., Shoga, E., Kannapiran, A., et al. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000795 · Cited by 127
Multitarget Therapeutic Strategies for Alzheimer’s Disease: Review on Emerging Target Combinations
Maramai, S., Benchekroun, M., Gabr, M. T., & Yahiaoui, S. (2020) · BioMed Research International · doi:10.1155/2020/5120230 · Cited by 121
PlantPepDB: A manually curated plant peptide database
Das, D., Jaiswal, M., Khan, F. N., Ahamad, S., & Kumar, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-59165-2 · Cited by 121
Cabri, W., Cantelmi, P., Corbisiero, D., Fantoni, T., Ferrazzano, L., Martelli, G., Mattellone, A., & Tolomelli, A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.697586 · Cited by 122
Wang, S. Y., Kim, H., Kwak, G., Yoon, H. Y., Jo, S. D., Lee, J. E., Cho, D., Kwon, I. C., & Kim, S. H. (2018) · Advanced Science · doi:10.1002/advs.201800852 · Cited by 118
Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics
Barman, P., Joshi, S., Sharma, S., Preet, S., Sharma, S., & Saini, A. (2023) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-023-10524-3 · Cited by 127
Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection
Karoyan, P., Vieillard, V., Gómez‐Morales, L., Odile, E., Guihot, A., Luyt, C. E., Denis, A., Grondin, P., & Lequin, O. (2021) · Communications Biology · doi:10.1038/s42003-021-01736-8 · Cited by 120
Tundo, G. R., Sbardella, D., Santoro, A. M., Coletta, A., Oddone, F., Grasso, G., Milardi, D., Lacal, P. M., Marini, S., Purrello, R., et al. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107579 · Cited by 119
Liscano, Y., Oñate-Garzón, J., & Delgado, J. P. (2020) · Molecules · doi:10.3390/molecules25184245 · Cited by 115
Strategies for oral delivery of bioactive peptides with focus on debittering and masking
Mirzapour‐Kouhdasht, A., McClements, D. J., Taghizadeh, M. S., Niazi, A., & García‐Vaquero, M. (2023) · npj Science of Food · doi:10.1038/s41538-023-00198-y · Cited by 120
Kumar, V., Lakkaboyana, S. K., Sharma, N., Chakraborty, P., Umesh, M., Pasrija, R., Thomas, J. B., Kalebar, V. U., Iyyappan, J., Awasthi, M. K., et al. (2023) · Case Studies in Chemical and Environmental Engineering · doi:10.1016/j.cscee.2023.100363 · Cited by 116
Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules
Castillo, R. R., Lozano, D., & Vallet‐Regí, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050432 · Cited by 116
Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites
Qiao, B., & de la Cruz, M. O. (2020) · ACS Nano · doi:10.1021/acsnano.0c04798 · Cited by 110
Metadata
- Authors
- Lau, J. L., & Dunn, M. K.
- Affiliations
- Ferring Research Institute (United States) (US)
- Corresponding author
- Dunn, Michael K.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 26
- Issue
- 10
- Pages
- 2700-2707
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W2724823461
- Cited by
- 1,879
- References
- 44
- Citations by year
- 2026: 146 · 2025: 179 · 2024: 205 · 2023: 236 · 2022: 299 · 2021: 275 · 2020: 278 · 2019: 194 · 2018: 59
- FWCI
- 13.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Bioorganic & Medicinal Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- peptide therapeutics, peptide drug discovery, clinical development, insulin, therapeutic areas
- MeSH terms
- Animals, Drug Evaluation, Humans, Peptides, Drug Approval, Drug Discovery, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
